Subscribe

Sanya Sukduang

Articles by Sanya Sukduang

Follow-on Biologics: A Patent Litigation Perspective

BySanya Sukduang,Jonathan Davies, PhD, Finnegan, Henderson, Farabow, Garrett & Dunner LLP

August 22nd 2009

In whatever form biosimilar legislation might take, patent holders will need to review their patent portfolios carefully

Latest Updated Articles

Follow-on Biologics: A Patent Litigation Perspective
August 22nd 2009

Trending on Pharmaceutical Commerce

FAQ: The Medicare GLP-1 Bridge Program

Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead

FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?

Q&A: Why Pharma Supply Chains Are Turning to AI

Wegovy Pill's UAE Debut Is a Distribution Story, Not Just a Market Entry